0000912282-24-000578.txt : 20240820 0000912282-24-000578.hdr.sgml : 20240820 20240820111018 ACCESSION NUMBER: 0000912282-24-000578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220404 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wijnker Dennis CENTRAL INDEX KEY: 0001902668 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 241223427 MAIL ADDRESS: STREET 1: 536 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 form4.xml X0508 4 2022-04-04 0000948320 LifeMD, Inc. LFMD 0001902668 Wijnker Dennis 536 FIFTH AVENUE SUITE 400 NEW YORK NY 10001 true Chief Technology Officer false Common Stock 2022-04-04 4 A 0 20000 A 20000 D Common Stock 2024-08-18 4 A 0 80000 A 100000 D Stock Option (Right to Buy) 3.78 2024-08-18 4 D 0 80000 D Common Stock 80000 0 D The restricted shares vest in full on April 4, 2025. The options are being cancelled in exchange for 205,000 restricted shares, with 40,000 shares vesting on January 1, 2025; 40,000 shares vesting on January 1, 2026; and a remaining 125,000 performance shares to be reported on settlement. The options vest and become exercisable in equal monthly tranches, based on passage of time, over the 36 months following the grant date December 29, 2021. /s/ Dennis Wijnker 2024-08-19